Mitchell Jones
Net worth: 28 118 $ as of 2026-05-30
Net worth: 28 118 $ as of 2026-05-30
Dr. Mitchell L.
Jones is a President & Chief Medical Officer at Palisade Bio, Inc. Dr. Jones was previously employed as a Vice President-Corporate Development & Strategy by Chemomab Therapeutics Ltd., a Vice President-Clinical Discovery & Development by Finch Therapeutics Group, Inc., a VP- Innovation & Clinical Development by Biora Therapeutics, Inc., a Head-Research & Development by Interface Therapeutics, Inc., and a Director, VP-Product Discovery & Design by Micropharma Ltd. He received his undergraduate degree from McGill University, a graduate degree from McGill University and a doctorate degree from McGill University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PALISADE BIO, INC. 0.01% | 2026-03-19 | 13,263 ( 0.01% ) | 28 118 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| PALISADE BIO, INC. | President | - |
| Companies | Position | End |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Corporate Officer/Principal | 2023-10-31 |
| FINCH THERAPEUTICS GROUP, INC. | Corporate Officer/Principal | 2022-10-31 |
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-06-30 |
Interface Therapeutics, Inc. | Founder | - |
Micropharma Ltd.
Micropharma Ltd. Pharmaceuticals: MajorHealth Technology Formulates, manufactures & sells functional food, neutraceuticals and pharmaceutical products | Founder | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 7 |
|---|---|
Micropharma Ltd.
Micropharma Ltd. Pharmaceuticals: MajorHealth Technology Formulates, manufactures & sells functional food, neutraceuticals and pharmaceutical products | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biora Therapeutics, Inc.
Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Interface Therapeutics, Inc. |
Select your edition
All financial news and data tailored to specific country editions